期刊文献+

糖尿病神经病变相关因素分析 被引量:18

Correlation Factors of Diabetes Nervous Lesion
下载PDF
导出
摘要 目的:探讨影响糖尿病患者并发神经病变的多种因素。方法:对580例糖尿病患者临床资料进行回顾性分析,着重研究糖尿病神经病变与年龄、病程、糖化血红蛋白(HbA1c)、体重指数(BMI)、下肢动脉血管B超评分等指标的相关性。结果:1型糖尿病仅病程、HbA1c、下肢动脉血管彩超评分与神经病变相关,而在2型糖尿病中除上述因素外,年龄、性别、BMI同时进入回归方程(P<0.05)。结论:糖尿病患者并发神经病变是多因素作用的结果,不同类型糖尿病影响因素存在差异。 Objective: To investigate correlation factors of diabetes nervous lesion. Methods. Clinical data about 580 cases of diabetes with nervous lesion were analyzed for relationship between neuropathy and age, course of disease, HbAlc, body mass index and score of ultrasonic artery examination. Results: In type 1 diabetes, course of disease, HbAlc, and score of ultrasonic artery examination were significantly correlated with diabetes nervous lesion. Besides these factors, age, gender and BMI were parameters of the regression equation (P〈0.05) in type Ⅱ diabetes. Conclusion: Diabetes nervous lesion could be the consequence of multiple factors. The factors are different in different types of diabetes.
出处 《实用临床医学(江西)》 CAS 2006年第10期46-48,共3页 Practical Clinical Medicine
关键词 糖尿病神经病变 神经传导速度 下肢动脉血管B超 diabetes nervous lesion nerve conduction velocity ultrasonic artery examination
  • 相关文献

参考文献9

二级参考文献44

  • 1Cameron NE,Eaton SE,Cotter MA,et al.Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.Diabetologia,2001,44:1973-1988.
  • 2Wada R,Nishizawa Y,Yagihashi N,et al.Effects of OPB-9195,anti-glycation agent,on experimental diabetic neuropathy.Eur J Clin Invest,2001,31:513-520.
  • 3Ziegler D.Therapy with antioxidants in human diabetic neuropathy.J Neurochem,2003,85(Suppl 2):15.
  • 4Takigawa T,Yasuda H,Terada M,et al.Increases in K+ conductance and Ca 2+influx under high glucose with suppressed Na+/K+-pump activity in rat myelinated nerve fibers.Neuroreport,2000,11:2547-2551.
  • 5Shimizu H,Ohtani KI,Tsuchiya T,et al.Aldose reductase mRNA expression is associated with rapid development of diabetic microangiopathy in Japanese type 2 diabetic (T2DM) patients.Diabetes Nutr Metab,2000,13:75-79.
  • 6Asano T,Saito Y,Kawakami M,et al.Fidarestat (SNK-860),a potent aldose reductase inhibitor,normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients.J Diabetes Complications,2002,16:133-138.
  • 7Cameron NE,Cotter MA.Vascular changes in animal models of diabetic neuropathy.J Neurochem,2003,85(Suppl 2):14.
  • 8Hounsom L,Corder R,Patel J,et al.Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy.Diabetologia,2001,44:424-428.
  • 9Purves T,Middlemas A,Agthong S,et al.A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy.FASEB J,2001,15:2508-2514.
  • 10Valls CJ,Povedano M,Montero J,et al.Diabetic polyneuropathy,axonal or demyelinating.Electromyogr Clin Neurophysiol,2002,42:3-6.

共引文献138

同被引文献122

引证文献18

二级引证文献184

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部